Qin, Chong et al. published their patent in 2021 |CAS: 1211568-27-2

The Article related to heterocyclyl androgen receptor modulator antitumor preparation, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Synthetic Route of 1211568-27-2

On November 9, 2021, Qin, Chong; Chen, Yiming; Zhong, Tengjiang; Zhang, Sai; Ge, Ling published a patent.Synthetic Route of 1211568-27-2 The title of the patent was High-efficiency androgen receptor modulator and its application. And the patent contained the following:

A high-efficiency androgen receptor modulator (e.g., I) having wide application in field of pharmaceuticals is provided. The androgen receptor (AR) modulator contains the E3 ubiquitin ligase ligand combined with an androgen receptor (AR) modulator. The androgen receptor (AR) modulators and their pharmaceutical composition are used in preparation of antiandrogen drugs. The experimental process involved the reaction of tert-Butyl 4-(piperidin-4-ylmethyl)piperazine-1-carboxylate(cas: 1211568-27-2).Synthetic Route of 1211568-27-2

The Article related to heterocyclyl androgen receptor modulator antitumor preparation, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Synthetic Route of 1211568-27-2

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics